tradingkey.logo
tradingkey.logo
Search

Tempus AI Inc

TEM
Add to Watchlist
43.870USD
-0.420-0.95%
Close 07-31 16:00ETQuotes delayed by 15 min
7.92BMarket Cap
LossP/E TTM

Tempus AI Inc

43.870
-0.420-0.95%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.95%

5 Days

+2.76%

1 Month

-24.27%

6 Months

-26.66%

Year to Date

-25.71%

1 Year

-22.48%

Key Figures
46.240Open
46.298High
7.31MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.06%Turnover Ratio
44.290Prev. Close
42.300Low
229.20MTurnover
LossP/E Static
17.77P/B
0.00%Div Yield TTM
-16.47%ROA
104.32052wk High
1.24Volume Ratio
-746.33MNet Profit
180.24MShares
-1.7110EPS TTM
--Beta
-81.58%ROE
41.73052wk Low
9.03%Amplitude
64.13%Gross Margin
7.92BMarket Cap
-6.61Reward/Risk
4.01%Risk Rate

TradingKey Stock Score of Tempus AI Inc

Currency: USD Updated: 2026-07-31

Key Insights

Tempus AI Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 68 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 68.37.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tempus AI Inc's Score

Industry at a Glance

Industry Ranking
68 / 385
Overall Ranking
143 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Tempus AI Inc Highlights

StrengthsRisks
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 139.14% year-on-year.
Fairly Valued
The company’s latest PE is -25.64, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 109.28M shares, increasing 5.45% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 9.21M shares of this stock.

Analyst Rating

Based on 20 analysts
Buy
Current Rating
68.368
Target Price
+64.54%
Upside Space

Tempus AI Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 20 analysts
Buy
Current Rating
68.368
Target Price
+64.54%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Tempus AI Inc
TEM
20
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(2)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-2.229
Sell
RSI(14)
38.004
Neutral
STOCH(KDJ)(9,3,3)
28.080
Buy
ATR(14)
3.208
Low Volatility
CCI(14)
-57.479
Neutral
Williams %R
83.825
Oversold
TRIX(12,20)
-0.890
Sell
StochRSI(14)
90.825
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
43.104
Buy
MA10
44.857
Sell
MA20
51.214
Sell
MA50
51.027
Sell
MA100
50.242
Sell
MA200
59.397
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Tempus AI Inc Info

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Ticker SymbolTEM
CompanyTempus AI Inc
CEOLefkofsky (Eric P)
Websitehttps://investors.tempus.com/

Shareholders

Shareholders
Shareholders
Proportion
Blue Media, LLC
9.05%
BK TL21 LLC
7.36%
Lefkofsky (Eric Paul)
7.19%
ARK Investment Management LLC
5.51%
Gray Media, LLC
5.09%
Other
65.81%

FAQs

What is the current price of Tempus AI Inc (TEM)?

The current price of Tempus AI Inc (TEM) is 43.87.

What is the symbol of Tempus AI Inc?

The ticker symbol of Tempus AI Inc is TEM.

What is the 52-week high of Tempus AI Inc?

The 52-week high of Tempus AI Inc is 104.32.

What is the 52-week low of Tempus AI Inc?

The 52-week low of Tempus AI Inc is 41.73.

What is the market capitalization of Tempus AI Inc?

The market capitalization of Tempus AI Inc is 7.91B.

Is Tempus AI Inc (TEM) currently rated as Buy, Hold, or Sell?

According to analysts, Tempus AI Inc (TEM) has an overall rating of Buy, with a price target of 68.37.

What is the Earnings Per Share (EPS TTM) of Tempus AI Inc (TEM)?

The Earnings Per Share (EPS TTM) of Tempus AI Inc (TEM) is -1.41.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.